161 related articles for article (PubMed ID: 25224615)
1. Community and research staff collaboration for development of materials to inform microbicide study participants in Africa.
Woodsong C; Mutsambi JM; Ntshele S; Modikoe P
J Int AIDS Soc; 2014; 17(3 Suppl 2):19156. PubMed ID: 25224615
[TBL] [Abstract][Full Text] [Related]
2. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
[TBL] [Abstract][Full Text] [Related]
3. Women and ARV-based HIV prevention - challenges and opportunities.
Geary CW; Bukusi EA
J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
5. ARV-based HIV prevention for women - where we are in 2014.
Mastro TD; Sista N; Abdool-Karim Q
J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
[TBL] [Abstract][Full Text] [Related]
6. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
[TBL] [Abstract][Full Text] [Related]
7. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
8. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
9. The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
Ferguson LM; Rohan LC
Ther Deliv; 2011 Dec; 2(12):1535-50. PubMed ID: 22468220
[TBL] [Abstract][Full Text] [Related]
10. WHO guidance grounded in a comprehensive approach to sexual and reproductive health and human rights: topical pre-exposure prophylaxis.
Lusti-Narasimhan M; Khosla R; Baggaley R; Temmerman M; McGrory E; Farley T
J Int AIDS Soc; 2014; 17(3 Suppl 2):19279. PubMed ID: 25224620
[TBL] [Abstract][Full Text] [Related]
11. An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings.
MacQueen KM; Tolley EE; Owen DH; Amico KR; Morrow KM; Moench T; Friend DR; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19158. PubMed ID: 25224617
[TBL] [Abstract][Full Text] [Related]
12. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
Venables E; Stadler J
Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
[TBL] [Abstract][Full Text] [Related]
13. Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning.
Lin AH; Breger TL; Barnhart M; Kim A; Vangsgaard C; Harris E
J Int AIDS Soc; 2014; 17(3 Suppl 2):19162. PubMed ID: 25224619
[TBL] [Abstract][Full Text] [Related]
14. Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
PLoS One; 2021; 16(1):e0244652. PubMed ID: 33411782
[TBL] [Abstract][Full Text] [Related]
15. Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.
Vallely A; Shagi C; Lees S; Shapiro K; Masanja J; Nikolau L; Kazimoto J; Soteli S; Moffat C; Changalucha J; McCormack S; Hayes RJ
BMC Med Ethics; 2009 Oct; 10():17. PubMed ID: 19814830
[TBL] [Abstract][Full Text] [Related]
16. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
[TBL] [Abstract][Full Text] [Related]
19. To What did They Consent? Understanding Consent Among Low Literacy Participants in a Microbicide Feasibility Study in Mazabuka, Zambia.
Munalula-Nkandu E; Ndebele P; Siziya S; Munthali JC
Dev World Bioeth; 2015 Dec; 15(3):248-56. PubMed ID: 25132499
[TBL] [Abstract][Full Text] [Related]
20. Microbicide research in developing countries: have we given the ethical concerns due consideration?
Moodley K
BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
